Works matching DE "SOFOSBUVIR"

Results: 562
    1

    Ledipasvir‐sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection.

    Published in:
    Liver International, 2018, v. 38, n. 9, p. 1552, doi. 10.1111/liv.13685
    By:
    • Asahina, Yasuhiro;
    • Itoh, Yoshito;
    • Ueno, Yoshiyuki;
    • Matsuzaki, Yasushi;
    • Takikawa, Yasuhiro;
    • Yatsuhashi, Hiroshi;
    • Genda, Takuya;
    • Ikeda, Fusao;
    • Matsuda, Takuma;
    • Dvory‐Sobol, Hadas;
    • Jiang, Deyuan;
    • Massetto, Benedetta;
    • Osinusi, Anu O.;
    • Brainard, Diana M.;
    • McHutchison, John G.;
    • Kawada, Norifumi;
    • Enomoto, Nobuyuki
    Publication type:
    Article
    2

    Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir‐experienced, NS5A treatment‐naïve patients: Findings from two randomized trials.

    Published in:
    Liver International, 2018, v. 38, n. 6, p. 1010, doi. 10.1111/liv.13616
    By:
    • Tam, Edward;
    • Luetkemeyer, Anne F.;
    • Mantry, Parvez S.;
    • Satapathy, Sanjaya K.;
    • Ghali, Peter;
    • Kang, Minhee;
    • Haubrich, Richard;
    • Shen, Xianlin;
    • Ni, Liyun;
    • Camus, Gregory;
    • Copans, Amanda;
    • Rossaro, Lorenzo;
    • Guyer, Bill;
    • Brown, Jr, Robert S.;
    • the RESCUE and ACTG A5348 study investigators
    Publication type:
    Article
    3
    4
    5
    6

    High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4.

    Published in:
    Liver International, 2017, v. 37, n. 12, p. 1823, doi. 10.1111/liv.13470
    By:
    • Mariño, Zoe;
    • Pascasio‐Acevedo, Juan M.;
    • Gallego, Adolfo;
    • Diago, Moisés;
    • Baliellas, Carme;
    • Morillas, Rosa;
    • Prieto, Martín;
    • Moreno, José M.;
    • Sánchez‐Antolín, Gloria;
    • Vergara, Mercedes;
    • Forné, Montserrat;
    • Fernández, Inmaculada;
    • Castro, María A.;
    • Pascual, Sonia;
    • Gómez, Alexandra;
    • Castells, Lluis;
    • Montero, José L.;
    • Crespo, Javier;
    • Calleja, José L.;
    • García‐Samaniego, Javier
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy.

    Published in:
    Liver International, 2017, v. 37, n. 5, p. 678, doi. 10.1111/liv.13322
    By:
    • Donato, Maria Francesca;
    • Morelli, Cristina;
    • Romagnoli, Renato;
    • Invernizzi, Federica;
    • Mazzarelli, Chiara;
    • Iemmolo, Rosa Maria;
    • Montalbano, Marzia;
    • Lenci, Ilaria;
    • Bhoori, Sherrie;
    • Pieri, Giulia;
    • Berardi, Sonia;
    • Caraceni, Paolo;
    • Martini, Silvia;
    • Angeli, Paolo;
    • Belli, Luca Saverio;
    • Bernabucci, Veronica;
    • Malinverno, Federica;
    • Monico, Sara;
    • Ottobrelli, Antonio;
    • Romano, Antonietta
    Publication type:
    Article
    15

    Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life study.

    Published in:
    Liver International, 2017, v. 37, n. 5, p. 653, doi. 10.1111/liv.13288
    By:
    • Pellicelli, Adriano M.;
    • Pace Palitti, Valeria;
    • Vignally, Pascal;
    • Ceccherini ‐ Silberstein, Francesca;
    • Siciliano, Massimo;
    • Giannelli, Valerio;
    • Moretti, Alessandra;
    • Tarquini, Pierluigi;
    • Scifo, Gaetano;
    • Messina, Vincenzo;
    • Ascione, Antonio;
    • Izzi, Antonio;
    • Marignani, Massimo;
    • D'Ambrosio, Cecilia;
    • Fondacaro, Lucia;
    • Ettorre, Giuseppe M.;
    • Ialongo, Pasquale;
    • Sacco, Rodolfo;
    • Perno, Carlo F.;
    • Barbarini, Giorgio
    Publication type:
    Article
    16

    Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.

    Published in:
    Liver International, 2017, v. 37, n. 4, p. 534, doi. 10.1111/liv.13266
    By:
    • Eletreby, Rasha;
    • Elakel, Wafaa;
    • Said, Mohamed;
    • El Kassas, Mohamed;
    • Seif, Sameh;
    • Elbaz, Tamer;
    • El Raziky, Maissa;
    • Abdel Rehim, Siham;
    • Zaky, Samy;
    • Fouad, Rabab;
    • Gamal Eldeen, Hadeel;
    • Abdo, Mahmoud;
    • Korany, Mohamed;
    • Yosry, Ayman;
    • El Serafy, Magdy;
    • El ‐ Sayed, Manal Hamdy;
    • ElShazly, Yehia;
    • Waked, Imam;
    • Doss, Wahid;
    • Esmat, Gamal
    Publication type:
    Article
    17

    Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies.

    Published in:
    Liver International, 2017, v. 37, n. 4, p. 514, doi. 10.1111/liv.13327
    By:
    • Di Maio, Velia C.;
    • Cento, Valeria;
    • Lenci, Ilaria;
    • Aragri, Marianna;
    • Rossi, Piera;
    • Barbaliscia, Silvia;
    • Melis, Michela;
    • Verucchi, Gabriella;
    • Magni, Carlo F.;
    • Teti, Elisabetta;
    • Bertoli, Ada;
    • Antonucci, FrancescoPaolo;
    • Bellocchi, Maria C.;
    • Micheli, Valeria;
    • Masetti, Chiara;
    • Landonio, Simona;
    • Francioso, Simona;
    • Santopaolo, Francesco;
    • Pellicelli, Adriano M.;
    • Calvaruso, Vincenza
    Publication type:
    Article
    18
    19

    Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis.

    Published in:
    Liver International, 2017, v. 37, n. 1, p. 62, doi. 10.1111/liv.13193
    By:
    • Martini, Silvia;
    • Sacco, Marco;
    • Strona, Silvia;
    • Arese, Daniele;
    • Tandoi, Francesco;
    • Dell Olio, Dominic;
    • Stradella, Davide;
    • Cocchis, Donatella;
    • Mirabella, Stefano;
    • Rizza, Giorgia;
    • Magistroni, Paola;
    • Moschini, Pamela;
    • Ottobrelli, Antonio;
    • Amoroso, Antonio;
    • Rizzetto, Mario;
    • Salizzoni, Mauro;
    • Saracco, Giorgio M.;
    • Romagnoli, Renato
    Publication type:
    Article
    20
    21
    22
    23

    A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.

    Published in:
    Liver International, 2016, v. 36, n. 8, p. 1101, doi. 10.1111/liv.13082
    By:
    • Kao, Jia ‐ Horng;
    • Chien, Rong ‐ Nan;
    • Chang, Ting ‐ Tsung;
    • Peng, Cheng ‐ Yuan;
    • Hu, Tsung ‐ Hui;
    • Lo, Gin ‐ Ho;
    • Wang, Horng ‐ Yuan;
    • Chen, Jyh ‐ Jou;
    • Yang, Jenny C.;
    • Knox, Steven J.;
    • Han, Lingling;
    • Mo, Hongmei;
    • Mathias, Anita;
    • Brainard, Diana M.;
    • Sheen, I ‐ Shyan;
    • Hsu, Yu ‐ Chun;
    • Chu, Chi ‐ Jen;
    • Chuang, Wan ‐ Long
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Hepatitis C: A Pharmacological Therapeutic Update.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 8, p. 1568, doi. 10.3390/jcm10081568
    By:
    • Santander Ballestín, Sonia;
    • Gómez Martín, David;
    • Lorente Pérez, Sara;
    • Luesma Bartolomé, María José
    Publication type:
    Article
    43
    44
    45
    46
    47
    48

    Real‐life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 201, doi. 10.1111/apt.18020
    By:
    • Ruiz‐Cobo, Juan Carlos;
    • Llaneras, Jordi;
    • Forns, Xavier;
    • Gallego Moya, Adolfo;
    • Conde Amiel, Isabel;
    • Arencibia, Ana;
    • Diago, Moises;
    • García‐Samaniego, Javier;
    • Castellote, Jose;
    • Llerena, Susana;
    • Rodríguez‐Seguel, Elisa;
    • Mateos, Beatriz;
    • Rodríguez, Manuel;
    • Rosales Zabal, Jose Miguel;
    • Fernández, Inmaculada;
    • Calleja, Jose Luis;
    • Morillas, Rosa María;
    • Montoliu, Silvia;
    • Andrade, Raul J.;
    • Badia Aranda, Ester
    Publication type:
    Article
    49
    50